These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2388047)

  • 21. Hepatitis D virus infection in children with acute or chronic hepatitis B virus infection in Taiwan.
    Hsu HY; Chang MH; Chen DS; Lee CY
    J Pediatr; 1988 Jun; 112(6):888-92. PubMed ID: 3373392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of HBV and HDV replicative activity in HBsAg-positive intravenous drug addicts with immune deficiency due to HIV.
    Monno L; Angarano G; Santantonio T; Milella M; Carbonara S; Fiore JR; Fico C; Pastore G
    J Med Virol; 1991 Jul; 34(3):199-205. PubMed ID: 1681028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroepidemiology of hepatitis B and D virus infection among intravenous drug addicts in Israel.
    Dan M; Rock M; Lilos P; Shany SB
    Int J Epidemiol; 1993 Feb; 22(1):140-3. PubMed ID: 8449634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis D virus infection among hepatitis B virus surface antigen positive individuals in Upper Egypt: Prevalence and clinical features.
    Makhlouf NA; Morsy KH; Mahmoud AA
    J Infect Public Health; 2019; 12(3):350-356. PubMed ID: 30833193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Retrospective (1970-1984) serological study of delta antigen and antibody. Observations on seroconversion and absence of delta in non-A, non-B hepatitis].
    Stroun J; Peitrequin R; Frei PC
    Schweiz Med Wochenschr; 1987 Feb; 117(9):307-14. PubMed ID: 3105053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis D outbreak among children in a hepatitis B hyper-endemic settlement in Greenland.
    Børresen ML; Olsen OR; Ladefoged K; McMahon BJ; Hjuler T; Panum I; Simonetti J; Jones C; Krarup H; Koch A
    J Viral Hepat; 2010 Mar; 17(3):162-70. PubMed ID: 19780937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to hepatitis delta virus in intravenous drug addicts and male homosexuals in Spain.
    León P; López JA; Contreras G; Echevarría JM
    Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):533-5. PubMed ID: 3141166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatitis B and hepatitis delta in young inmates].
    Bayas JM; Bruguera M; Martín V; Mayor A; de la Fuente ML; Laliga A; Salleras L
    Med Clin (Barc); 1990 Feb; 94(5):164-8. PubMed ID: 2325476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of hepatitis D virus infection: changes in the last 14 years.
    Navascués CA; Rodríguez M; Sotorrío NG; Sala P; Linares A; Suárez A; Rodrigo L
    Am J Gastroenterol; 1995 Nov; 90(11):1981-4. PubMed ID: 7485005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
    Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
    J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B, C, and D virus infection showing distinct patterns between injection drug users and the general population.
    Chen F; Zhang J; Guo F; Wen B; Luo S; Yuan D; Lin Y; Ou W; Tang P; Dai G; Li F; Liu W; Qu X
    J Gastroenterol Hepatol; 2017 Feb; 32(2):515-520. PubMed ID: 27248508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status.
    Nicolini LA; Taramasso L; Schiavetti I; Giannini EG; Beltrame A; Feasi M; Cassola G; Grasso A; Bartolacci V; Sticchi L; Picciotto A; Viscoli C;
    Antivir Ther; 2015; 20(2):193-7. PubMed ID: 24963642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis virus infection and liver disease in injecting drug users who died suddenly.
    McCruden EA; Hillan KJ; McKay IC; Cassidy MT; Clark JC
    J Clin Pathol; 1996 Jul; 49(7):552-5. PubMed ID: 8813952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HCV, HIV, HBV and HDV infections in intravenous drug addicts.
    Coppola RC; Manconi PE; Piro R; Di Martino ML; Masia G
    Eur J Epidemiol; 1994 Jun; 10(3):279-83. PubMed ID: 7859838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis delta in HIV/HBV co-infected patients in Brazil: is it important?
    Mendes-Correa MC; Gomes-Gouvêa MS; Alvarado-Mora MV; Da Silva MH; Lázari C; Cavalcanti NC; Alonso FK; Carpinelli CC; Uip DE; Pinho JR
    Int J Infect Dis; 2011 Dec; 15(12):e828-32. PubMed ID: 21999909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology and long-term consequences of hepatitis delta virus infection in the Yucpa Indians of Venezuela.
    Hadler SC; Alcala de Monzon M; Rivero D; Perez M; Bracho A; Fields H
    Am J Epidemiol; 1992 Dec; 136(12):1507-16. PubMed ID: 1288280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis D virus antibody in HBsAg-positive and HBsAg-negative substance abusers with chronic liver disease.
    Novick DM; Farci P; Karayiannis P; Gelb AM; Stenger RJ; Kreek MJ; Thomas HC
    J Med Virol; 1985 Apr; 15(4):351-6. PubMed ID: 3884737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
    Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroepidemiology of hepatitis D (delta agent) and hepatitis B among Virginia State prisoners.
    Tucker RM; Gaffey MJ; Fisch MJ; Kaiser DL; Guerrant RL; Normansell DE
    Clin Ther; 1987; 9(6):622-8. PubMed ID: 3440274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.